KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.05 $8.45 Friday, 26th Apr 2024 ABEO stock ended at $3.26. This is 2.19% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.62% from a day low at $3.20 to a day high of $3.38.
90 days $3.05 $9.01
52 weeks $2.85 $9.01

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Oct 29, 2021 $20.25 $20.93 $20.00 $20.31 23 128
Oct 28, 2021 $21.15 $21.28 $19.78 $20.25 61 228
Oct 27, 2021 $22.00 $22.03 $21.05 $21.25 17 069
Oct 26, 2021 $22.00 $22.00 $21.25 $21.95 19 630
Oct 25, 2021 $21.25 $22.00 $21.00 $21.00 27 081
Oct 22, 2021 $22.50 $22.50 $21.50 $21.50 26 574
Oct 21, 2021 $21.98 $23.00 $21.98 $22.60 24 617
Oct 20, 2021 $22.13 $23.00 $22.13 $22.50 14 006
Oct 19, 2021 $22.31 $22.74 $22.25 $22.47 15 708
Oct 18, 2021 $23.10 $23.20 $22.00 $22.28 39 603
Oct 15, 2021 $22.00 $23.38 $22.00 $22.75 26 758
Oct 14, 2021 $22.00 $22.68 $22.00 $22.27 19 599
Oct 13, 2021 $22.25 $23.00 $22.00 $22.01 33 337
Oct 12, 2021 $22.83 $23.38 $22.37 $22.44 17 679
Oct 11, 2021 $24.06 $24.06 $22.00 $23.00 49 047
Oct 08, 2021 $24.21 $24.50 $23.50 $23.65 13 419
Oct 07, 2021 $23.71 $25.00 $23.71 $23.76 22 592
Oct 06, 2021 $23.26 $25.75 $22.50 $23.94 54 351
Oct 05, 2021 $26.25 $26.75 $20.94 $23.76 154 794
Oct 04, 2021 $27.25 $27.75 $26.25 $26.25 20 496
Oct 01, 2021 $28.50 $28.50 $27.00 $27.50 16 333
Sep 30, 2021 $27.25 $28.38 $27.00 $28.00 16 131
Sep 29, 2021 $28.75 $29.25 $27.25 $27.50 31 078
Sep 28, 2021 $29.25 $29.50 $28.50 $28.50 14 809
Sep 27, 2021 $29.25 $29.88 $28.25 $29.50 30 205
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT